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Zinc finger transcription factors of the Snail/Slug and ZEB-1/SIP1 families control epithelial-mesenchymal transitions in
development in cancer. Here, we studied SIP1-regulated mesenchymal conversion of epidermoid A431 cells. We found
that concomitant with inducing invasive phenotype, SIP1 inhibited expression of cyclin D1 and induced hypophosphor-
ylation of the Rb tumor suppressor protein. Repression of cyclin D1 was caused by direct binding of SIP1 to three
sequence elements in the cyclin D1 gene promoter. By expressing exogenous cyclin D1 in A431/SIP1 cells and using RNA
interference, we demonstrated that the repression of cyclin D1 gene by SIP1 was necessary and sufficient for Rb
hypophosphorylation and accumulation of cells in G1 phase. A431 cells expressing SIP1 along with exogenous cyclin D1
were highly invasive, indicating that SIP1-regulated invasion is independent of attenuation of G1/S progression.
However, in another epithelial-mesenchymal transition model, gradual mesenchymal conversion of A431 cells induced by
a dominant negative mutant of E-cadherin produced no effect on the cell cycle. We suggest that impaired G1/S phase
progression is a general feature of cells that have undergone EMT induced by transcription factors of the Snail/Slug and
ZEB-1/SIP1 families.
INTRODUCTION
An important event in the development of malignant epi-
thelial tumors is epithelial-mesenchymal transition (EMT), a
process of generation of motile and invasive mesenchymal
cells from polarized epithelia. Because EMT plays a funda-
mental role at certain stages of normal development (gas-
trulation, neural crest migration, somitogenesis), it has been
suggested that some elements of embryonic transdifferen-
tiation programs are exploited by cells of growing carci-
noma (Thiery, 2003). Cells undergoing EMT are character-
ized by massive alterations in gene expression patterns.
They acquire expression of mesenchymal but loose epithelial
markers. A central event in EMT is loss of epithelial cadherin
(E-cadherin), a surface receptor that plays an essential role in
the formation of adherens junctions and that is often mu-
tated or lost in cancer cells (Thiery and Chopin, 1999, Thiery,
2003).
In recent years, several direct transcriptional repressors of
E-cadherin (Snail, Slug, ZEB-1, SIP1, and E47) have been
identified (Batlle et al., 2000; Cano et al., 2000; Comijn et al.,
2001; Perez-Moreno et al., 2001; Bolos et al., 2003; Eger et al.,
2005). These proteins act downstream in EMT-inducing sig-
nal transduction pathways activated by TGF, FGF, and
EGF growth factors, integrin engagement, and hypoxia
(Imai et al., 2003; De Craene et al., 2005a; Krishnamachary et
al., 2006; Imamichi et al., 2007). ZEB-1/SIP1 and Snail/Slug
family members directly interact with the response elements
in the proximal e-cadherin gene promoter and actively re-
press transcription recruiting transcriptional corepressors
such as CtBP or mSinA (Furusawa et al., 1999; Shy et al., 2003;
Peinado et al., 2004). More recently, direct repression of other
epithelial genes by Snail and SIP1 has been reported (De
Craene et al., 2005b; Vandewalle et al., 2005; Moreno-Bueno
et al., 2006). In addition, Snail/Slug and ZEB-1/SIP1 proteins
mediate up-regulation of genes implicated in cell invasion
and motility (e.g., vimentin, members of the matrix metal-
loproteinase (MMP) family of proteases, fibronectin). The
mechanisms of transcriptional activation is less clear; in
some cases, indirect activation of genes implicated in EMT
by Snail and SIP1 takes place (Jorda et al., 2005; Taki et al.,
2006). In contrast to Snail and Slug, ZEB-1, and SIP1 proteins
interact with transcriptional coactivators pCAF and p300
(Postigo et al., 2003; van Grunsven et al., 2006). This biochem-
ical difference may indicate that Snail and SIP1 family mem-
bers activate expression of mesenchymal markers via funda-
mentally different mechanisms. In vivo studies demonstrated
that Snail/Slug and ZEB-1/SIP1 proteins have different
functions in embryonic development and are involved in the
control of distinct EMT programs. Snail regulates gastrula-
tion, and snai1/ mutant embryos exhibit severe defects in
EMT required for generation of the mesoderm cell layer
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(Carver et al., 2001). On the other hand, experiments with
snai2-deficient mice (Jiang et al., 1998) and generation of
conditional snai1/ knockout embryos demonstrated that
neither Snail nor Slug is required for the delamination and
migration of neural crest cells (Murray and Gridley, 2006). In
contrast, homozygous mutant embryos lacking zfhx1b, the
gene encoding SIP1, display early arrest in cranial neural
crest migration (van de Putte et al., 2003).
In a number of clinical studies, transcription of genes
encoding Snail/Slug and ZEB-1/SIP1 proteins has been de-
tected in breast (Blanco et al., 2002; Elloul et al., 2005), ovarian
(Elloul et al., 2005), gastric (Rosivatz et al., 2002), and hepa-
tocellular (Sugimachi et al., 2003) carcinoma cells, and Snail
immunoreactivity significantly correlated with breast cancer
metastasis (Zhou et al., 2004). Activation of Snail, Slug, E47,
ZEB1, and SIP1 is an important, but not the only instrument
that is utilized by cancer cells to acquire motile characteris-
tics. Inactivation of e-cadherin by gene mutations (Berx et al.,
1998; Guilford et al., 1998) or consistent cleavage of the
E-cadherin extracellular domain chronically exposed to ma-
trix metalloproteinases secreted by stromal cells may be
sufficient to trigger a process ultimately leading to EMT in
tumor cells (Lochter et al., 1997). Recently, we explored a
model of functional inhibition of E-cadherin in squamous
carcinoma cells A431 by a dominant negative E-cadherin
mutant (Andersen et al., 2005). Expression of this mutant
triggered a program of gradual EMT, which eventually re-
sulted in activation of vimentin and increased cell motility.
In nonpathological conditions, EMT represents the pro-
found de-differentiation program that must be incompatible
with cell proliferation (Burstyn-Cohen and Kalcheim, 2002).
Indeed, in 8.5 dpc mouse embryos, cells expressing Snail are
characterized by decreased incorporation of bromode-
oxyuridine (BrdU; Vega et al., 2004). In Madin-Darby canine
kidney (MDCK) cells and in primary keratinocytes, Snail
family members induce cell cycle arrest in G1 phase and
hypophosphorylation of the retinoblastoma (Rb) protein
(Vega et al., 2004; Turner et al., 2006). Complex cell cycle–
regulating networks are dependent on cell–cell adhesion,
integrin signaling, cell spreading, and actomyosin contrac-
tility (Walker et al., 2005). Therefore, there are many poten-
tial molecular schemes by which EMT may affect cell pro-
liferation in embryonic development and cancer. However,
in cancer cells, the interrelationship between cell growth and
EMT can be circumvented by the defects in the molecular
pathways controlling the cell cycle. In this study, we analyze
cell cycle progression in two EMT models based on condi-
tional expression of either SIP1 or a dominant negative
E-cadherin mutant Ec1WVM in the same cell line. We show
that SIP1, but not Ec1WVM, induces accumulation of cells in
the G1 phase of cell cycle. This effect is largely mediated by the
direct transcriptional repression of the cyclin D1 gene by SIP1.
MATERIALS AND METHODS
Plasmids
Vectors expressing myc-tagged wild-type SIP1 (pUHDmyc-SIP1) and myc-
tagged SIP1 with the mutated C-terminal Zn finger (pTREmyc-SIP1ZFmut) have
been described (Comijn et al., 2001; van Grunsven et al., 2003). To generate a
doxycycline (DOX)-regulated cyclin D1 expression vector (pBIcyclD1), the
cyclin D1 coding sequence was amplified and cloned into pBI vector (BD
Bioscience, Clontech, Palo Alto, CA). To analyze cyclin D1 promoter activ-
ity, we generated two luciferase reporter vectors, pwtCCND1LUC and
pmutCCND1LUC. To generate pwtCCND1LUC, a fragment of the cyclin D1
5-flanking sequence (1025 to 18) was cloned into pGL3 basic vector
(Promega Biotech, Madison, WI). To create pmutCCND1LUC, three Z-boxes
with coordinates 1014 to 1010; 857 to 853, and 300 to 290 were
mutated by introducing a single nucleotide substitution (5-AGGTG replaced
by 5-AGATG) using conventional PCR-based methods.
Cell Lines and Transfections
To generate A431 clones with the inducible expression of wild-type or mutant
SIP1 (Tet-On system), we used a clone of A431 cells expressing Tet-responsive
transcriptional activator rtTA (Andersen et al., 2005). Cells were transfected
either with the pUHDmyc-SIP1 or pTREmyc-SIP1ZFmut along with the pTK-
Hyg vector (BD Bioscience Clontech). Selection of stable clones was carried
out in the presence of 60 g/ml hygromycin B. Clones with concurrent
DOX-regulated expression of SIP1 and cyclin D1 were obtained by cotrans-
fecting A431/SIP1 cells with pBIcyclD1 and pPuro (BD Bioscience Clontech;
conveys resistance to puromycin), followed by the selection of puromycin-
resistant cells in the presence of 0.5 g/ml puromycin. Transfections of
plasmid DNA were performed by electroporation with a single pulse of 250
V and 250 Fd by using the Gene Pulser Xcell electroporation system (Bio-
Rad Laboratories, Hercules, CA). Established cell lines were cultured in
DMEM supplemented with 10% fetal bovine serum with or without DOX (2
g/ml).
Immunofluorescence
For immunofluorescent staining, cells were grown for 2 d in 10-well glass
microscope slides (VWR International, Fontenay-sous-Bois, France). Cells
were washed and fixed in acetone/methanol (1:1) solution for 3 min on ice.
After rinsing, the slides were incubated with primary antibodies for 1 h at
room temperature, rinsed, and incubated with Alexa 488–conjugated rabbit
anti-mouse IgG (Pierce, Rockford, IL) for 1 h. The anti-vinculin antibody was
from BD Biosciences, Transduction Laboratories. Cells were examined and
photographed using a confocal inverted microscope (Axiovert 200M; Zeiss,
Oberkochen, Germany). To monitor BrdU incorporation, cells were pulse-
labeled with BrdU for 40 min and stained with DAPI and an anti-BrdU
antibody (Roche, Mannheim, Germany) according to the protocols supplied
with the Detection kit I (Roche). Proportion of BrdU-positive cells was quan-
tified in several microscopic fields and are presented as mean  SD.
Western Blotting
Proteins (10 or 20 g) were denatured, separated on 6% or precast 4–20%
gradient SDS-polyacrylamide gels (Invitrogen, Carlsbad, CA), and then trans-
ferred to Immobilon-P membranes (Millipore, Bedford, MA) by the standard
procedure. After protein transfer, blots were incubated in blocking solution
with primary antibody at a dilution of 1:1000 (for anti-myc tag antibody, clone
9E10; Santa Cruz Biotechnology, Santa Cruz, CA) and 1:500 (for anti-cyclin
D1, anti-p21, anti-p16, anti-p27, and anti-Rb antibodies; Santa Cruz Biotech-
nology). Immunoreactive proteins were detected using an enhanced chemi-
luminescence system (Amersham Pharmacia Biotech, Piscataway, NJ).
cDNA Microarray Analysis
Construction of 20K microarrays, probe labeling, hybridization, and scanning
were carried out at the MicroArray Facility of the Flanders Interuniversity
Institute for Biotechnology. Changes in spot intensities 1.8 or 0.55 were
regarded as significant in this system.
RNA Interference
Purified and annealed synthetic oligonucleotides specific for cyclin D1 or
control small interfering RNA (siRNA) were purchased from Ambion (Aus-
tin, TX). Target sequence for cyclin D1 was validated previously by the
company. Cells (n  2  106) were transfected with 0.2 nmol of siRNA by
nucleofection technique in buffer V (nucleofection protocol T-20). The nucleo-
fector device and a nucleofection kit were obtained from Amaxa (Ko¨ln,
Germany) and used in accordance with the manufacturer’s recommendations.
At 48 h after transfection, cells were harvested, counted, and processed for
fluorescence-activated cell sorting (FACS) analysis or Western blotting.
Determination of Cyclin D1 mRNA Stability
Cells were maintained in the presence or absence of DOX for 48 h. Then,
actinomycin D (ActD) was added at the concentration of 5 g/ml for various
time periods. Total RNA was isolated, and transcription of cyclin D1, 28S
gene, and fosl1 was analyzed by RT-PCR or quantitative real time PCR.
FACS Analysis
A431/SIP1 and A431/SIP1/cyclD1 cells or cells nucleofected with siRNA
were grown in the presence or absence of DOX for 48 h, harvested, fixed in
70% ethanol, treated with RNase (1 mg/ml), and stained with propidium
iodide (PI; 50 g/ml). The cellular DNA content was evaluated using FACS
flow cytometer.
Three-dimensional Matrigel Invasion Assay
Invasion was analyzed in inverse invasion assay as previously described
(McGarry et al., 2004) with minor modifications. A431/SIP1 and A431/SIP1/
cyclD1 cells were maintained with or without DOX for 48 h. Cells (n  6 
104) were seeded on the underside of the polycarbonate filter of a Transwell
chamber containing 100 l of matrigel basement membrane matrix (Becton
J. Mejlvang et al.
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Dickinson, Oxford, United Kingdom) diluted 1:1. Cells were allowed to
adhere for 3 h and washed by DMEM. Transwell chambers were placed in
wells filled with 1 ml of DMEM with or without DOX. In 3 d, cells were fixed
in methanol and stained for 1 h in PI solution (10 g/ml). Optical sections
were scanned at 10-m intervals using the confocal microscope Zeiss Axio-
vert 200M. To perform statistical analysis of the invasive potential of A431/
SIP1 and A431/SIP1/cyclD1 cells, the amount of cells entering matrigel and
remaining at the filter was calculated in 12 optical fields. The values were
expressed as a percentage of cells that penetrated matrigel.
Cell Adhesion and Transwell Migration Assays
Cell adhesion assay was carried out essentially as previously described
(Mejlvang et al., 2007). Ninety-six–well tissue culture plates were coated with
50 g/ml human fibronectin or 50 g/ml rat collagen type I (all from BD
Biosciences). Cells were allowed to adhere for 15 min. In some experiments,
a blocking antibody AIIB2 known to prevent adhesion to both substrates
(Brockbank et al., 2005) has been mixed with the cells for 10 min before the
assay.
A directed transwell migration assay was performed using 24-well trans-
well plates containing 8-m pore-size polycarbonate filters (Corning Costar,
Cambridge, MA). Cells (n 105) were cultured with or without DOX for 48 h,
seeded in culture inserts, and maintained overnight. Adhered cells were
allowed to migrate toward gradient of serum used as a chemoattractant in the
lower chamber for 2 h. Cells that migrated to the underside of transwell filters
were fixed, stained with a Gurr rapid staining kit (BDH, Dagenham, United
Kingdom), and counted by bright-field microscopy at a magnification of200
in four random fields using the ImageJ program.
Nuclear Run-On Assay
Nuclear run-on assay was based on the incorporation of biotin-16-uridine-5-
triphosphate (biotin-16-UTP) in nascent transcripts according to Patrone et al.
(2000). Briefly, cells were maintained with or without DOX for 48 h. Cells were
harvested and consequently resuspended in buffer I (10 mM Tris-Cl, pH 7.4, 3
mM MgCl2, 10 mM NaCl, 150 mM sucrose, 0.5% NP40) or buffer II (10 mM
Tris-Cl, pH 7.4, 3 mM MgCl2, 10 mM NaCl, 150 mM sucrose) and centrifuged at
500  g for 10 min. Nuclei were then resuspended in buffer III (40% glycerol, 50
mM Tris-HCl, pH 8.5, 5 mM MgCl2, 0.1 mM EDTA) and quickly frozen.
To perform nuclear run-on reactions, 2  106 nuclei were incubated in a
reaction buffer (4 mM of each NTP, 200 mM KCl, 20 mM Tris-Cl, pH 8.0, 5 mM
MgCl2, 4 mM dithiothreitol, 200 mM sucrose) for 30 min at 29°C and stopped
by adding RNase-free DNase I. In some reactions (negative controls), 0.5 mM
UTP instead of biotin-16-UTP was used. Total RNA was isolated by TRIzol
(Invitrogen) extraction, and biotinylated RNA was purified using agarose-con-
jugated streptavidin beads. Beads were washed two times with 15% formamide
and five times with 2 SSC. Isolated biotinylated RNA was used for RT-PCR.
Real-time Quantitative PCR
RNA was isolated using TRIazol reagent. cDNA synthesis was carried out
using random hexamers and Superscript II (Invitrogen). PCR was performed
using SYBR Green PCR Master Mix in the PRISM 7700 Sequence Detection
System (Applied Biosystems, Foster City, CA). Primers were designed to
cross exon–exon boundaries and used at the concentration 900 nM. Each
sample was run in triplicate. The CT (threshold cycle when fluorescence
intensity exceeds 10 times the SD of the baseline fluorescence) values for the
target amplicon and endogenous control (28S) were determined for each
sample. Quantification was performed using the comparative CT method
(		CT).
Luciferase Reporter Assay
To determine transcriptional activity of cyclin D1 reporters, A431/SIP1 cells
were transfected with 1 g reporter constructs. The efficiency of each trans-
fection was monitored using 400 ng cotransfected -galactosidase expression
vector, pCMV-gal (BD Biosciences). Cells were maintained with DOX for
48 h and lysed, and the luciferase activity was measured with a Lumat LB9501
tube luminometer (Berthold Detection Systems, Pforzheim, Germany). The
luciferase activity was normalized to the activity of -galactosidase deter-
mined using o-nitrophenyl--d-galactopyranoside (Sigma, Poole, Dorset,
United Kingdom) as a chromogenic substrate.
Chromatin Immunoprecipitation Assay
A431/SIP1 cells were cultured for 24 h in the presence or absence of DOX.
Cross-linking, immunoprecipitation, and DNA purification were performed
using chromatin immunoprecipitation (ChIP)-IT kit (Active Motif, Carlsbad,
CA) according to the manufacturer’s protocol. Immunoprecipitated DNA was
analyzed by real-time quantitative PCR.
Statistics
Results are expressed as the mean  SD. Student’s t test was used to evaluate
the differences between groups.
RESULTS
SIP1-mediated EMT in A431 Cells: Switch from a
Proliferative to an Invasive State
To study the physiological effects of SIP1 in carcinoma cells,
we generated clones of the squamous carcinoma cell line
A431 with the DOX-regulated expression of 6xMyc-tagged
SIP1 (clone A431/SIP1). Treatment with DOX resulted in
rapid accumulation of SIP1 in 95–98% of nuclei of A431/
SIP1 cells, leading to cell scattering and dramatic morpho-
logical conversion from an epithelial cell state to a fibroblast-
like phenotype. On the other hand, A431 cells expressing
6xMyc-tagged SIP1 with the mutated C-terminal Zn-finger
retained entirely polarized epithelial morphology (Figure
1A). Expression of wild-type SIP1 promoted cytoplasmic
redistribution of the adherens junctions and tight junction
proteins (data not shown). The staining of DOX-treated cells
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Figure 1. SIP1 induces cell invasion and in-
hibits cell growth. (A) Characterization of
DOX-regulated A431 clones expressing SIP1
or SIP1ZFmut. Phase-contrast images of DOX-
inducible A431 cell clones expressing myc-
tagged SIP1 or SIP1ZFmut. Western blots show
the expression of wild-type or mutant SIP1 in
cells maintained with or without DOX for 48 h.
(B) Inverse invasion assay of DOX-treated or un-
treated A431/SIP1 and A431/SIPZFmut cells.
Confocal microscope sections of PI-stained
cells were used to analyze the invasion assay.
The row corresponding to 0 m shows cells on
the underside of the filter. Other sections show
cells invaded into matrigel at different dis-
tances as indicated. The experiment was re-
peated four times, and results of a typical ex-
periment are shown. (C) SIP1 inhibits cell
growth. A431/SIP1 or A431/SIP1ZFmut cells
were cultured with and without DOX, and cell
number was counted at different time points as
indicated. Experiments were repeated three
times with similar results. Data shown are
mean  SDs of triplicate experiments.
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with phalloidin or an anti-vinculin antibody indicated that
SIP1-inhibited cell–cell adhesion, but promoted formation of
focal adhesions and disappearance of F-actin from intercel-
lular borders (Supplementary Figure S1A). In addition,
SIP1-activated cell adhesion to collagen and fibronectin
(Supplementary Figure S1B). We used a cDNA microarray
technique to obtain a global view on the number of genes
regulated by SIP1 in A431 cells. Forty-eight hours of SIP1
induction led to prominent changes in gene expression pro-
files. We found that out of 20,000 genes analyzed, SIP1
repressed 281 genes by a factor of 0.55 or less and activated
204 genes by a factor of 1.8 or more (corresponds to the

2.4% of human genome; Supplementary Tables SIA and
SIB).
RT-PCR analysis of the selected genes demonstrated the
reliability of the microarray hybridization (Supplementary
Figure S2). Transcription of all genes tested was not affected
in cells expressing SIP1 with the inactivated C-terminal
Zn-finger domain. The largest cluster in a group of genes
down-regulated by SIP1 contained markers of epithelial
differentiation (components of epithelial microfilaments
and junctional proteins). Given that essential mesenchymal
genes (vimentin, fibronectin, and N-cadherin) were signifi-
cantly up-regulated by SIP1, we concluded that SIP1 acti-
vated a program of EMT in A431 cells. We aimed to
examine how the mesenchymal conversion of tumorigenic
cells influenced their invasive and proliferative proper-
ties. We examined effects of SIP1 on tumor cell invasion in
an inverse three-dimensional (3D) in vitro invasion assay.
As we expected, in the experimental conditions used in
this study, cells maintained without DOX were only min-
imally invasive. SIP1 induction strongly activated inva-
sion, and in the presence of DOX A431/SIP1 cells pene-
trated matrigel at the distance of more than 40 m (Figure
1B).
To analyze the effects of SIP1 on cell growth, we seeded
equal amounts of cells on six-well culture plates, maintained
them with and without DOX, and counted them in 24, 48, 72,
and 96 h. Already after 24 h of DOX-treatment, SIP1 signif-
icantly decreased the doubling time of A431 cells (p  0.05;
Figure 1C). Consistent with this observation, A431/SIP1
cells incubated with DOX for 48 h incorporated 3.2-fold less
BrdU than cells maintained in the absence of DOX (see
Figure 3C). As expected, expression of SIP1 with the mu-
tated C-terminal Zinc-finger domain produced no effect on
cell proliferation or matrigel invasion (Figure 1, B and C).
Taken together, these data demonstrated that SIP1-induced
EMT program encompasses a global genetic reprogramming
and switch from a proliferative to an invasive type of cell
behavior.
Transition into S Phase of the Cell Cycle Is Inhibited by
SIP1
Having demonstrated inhibition of cell growth by SIP1,
we analyzed the effect of SIP1 on cell cycle distribution.
FACS analysis of A431/SIP1 cell cultures maintained with
or without DOX for 48 h showed that SIP1 increased
proportion of cells in G1 phase (Figure 2A). Percent of
cells passing through S phase, G2, and mitosis was two
times lower in cells undergoing EMT (24  4 vs. 49  3%).
Because G1/S transition in mammalian cell cycle is regu-
lated by Rb pathway and phosphorylation of the Rb pro-
tein is critical for G1/S progression, we examined the
effect of SIP1 on the Rb phosphorylation. We found that in
our system, accumulation of cells in G1 phase of the cell
cycle was concomitant with the hypophosphorylation of
Rb (Figure 2B). Microarray analysis revealed strong (6.7-
fold) down-regulation of the CCND1 gene, which encodes
cyclin D1, a critical regulator of Rb phosphorylation (Sup-
plementary Table SIB). We confirmed SIP1-mediated re-
pression of cyclin D1 on both mRNA and protein levels.
Next, we analyzed expression of other key proteins reg-
ulating Rb phosphorylation and cell cycle progression
through G1 phase (Figure 2B). Whereas the mRNA levels
of cyclin D3, p21(Cip1), and p27(Kip1) remained not al-
tered upon SIP1 induction, transcription of cyclin D2 was
not detectable independently on the presence of DOX.
Western blot analysis demonstrated similar levels of
p27(Kip1) and lack of the expression of p16 protein in
SIP1-expressing and nonexpressing cells. Unexpectedly,
in the presence of SIP1, the expression of p21(Cip1) was
Figure 2. SIP1 negatively regulates G1/S transition. (A) FACS analysis of A431/SIP1 cells maintained in the absence or presence of DOX
for 48 h. The diagram shows mean SDs of triplicate experiments. p 0.0001 (t test). (B) Expression of molecules regulating G1/S transition
in A431/SIP1 cells. Cells were cultured with or without DOX for 48 h, and the expression of indicated genes was analyzed by Western
blotting or RT-PCR. Note the appearance of the hypophosphorylated form of Rb in DOX-treated cells.
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reduced on protein level, although mRNA level was not
affected (Figure 2B).
Cyclin D1 Down-Regulation Is Necessary and Sufficient
for SIP1-induced Changes in Cell Cycle Distribution
Cyclin D1 down-regulation correlated with Rb hypophos-
phorylation and accumulation of the cells in G1 phase of the
cell cycle. To analyze whether SIP1 affects cell cycle distri-
bution via cyclin D1, we used two approaches. First, we
inhibited endogenous cyclin D1 level in A431/SIP1 cells by
RNA interference (RNAi). The reduction in cyclin D1 levels
in A431/SIP1 cells caused by siRNA resulted in the accu-
mulation of cells in G1 and Rb hypophosphorylation, resem-
bling the effect of SIP1 (Figure 3A). In parallel experiments,
we generated clones of A431/SIP1 cells with simultaneous
DOX-regulated expression of SIP1 and cyclin D1 (Figure 3B,
clones 1–3). Although in the absence of DOX, all clones
retained epithelial phenotype, DOX treatment induced mor-
phological transformation and cell scattering, which was
identical to the effect produced by SIP1 in parental A431/
SIP1 cells (data not shown). In clone 1, activation of exoge-
nous cyclin D1 resulted in partial suppression of the effect of
SIP1 on total cyclin D1 level. In DOX-treated cells of clone 1,
Rb hypophosphorylation was partly suppressed, and the
proportion of cells retained in G1 dropped from 82 to 62%.
In clones 2 and 3, DOX treatment led to the very high cyclin
D1 expression significantly exceeding cyclin D1 levels in
DOX-untreated A431/SIP1 cells. In these clones, overexpres-
sion of cyclin D1 completely blocked Rb hypophosphoryla-
tion and abandoned the effect of SIP1 on cell cycle distribu-
tion (Figure 3B). Moreover, enforced expression of cyclin D1
bypassed the effect of SIP1 on the level of BrdU incorpora-
tion (Figure 3C). Taken together, these data indicate that
repression of cyclin D1 is indispensable for the effects of SIP1
on cell cycle distribution.
Ectopic Expression Cyclin D1 Does Not Interfere with the
Motile Behavior of SIP1-expressing Cells
Using 3D matrigel invasion assay, we found that cells simul-
taneously expressing SIP1 and cyclin D1 were at least as
invasive as cells expressing SIP1 only (Figure 4A). In addi-
tion, we analyzed migratory capabilities of A431/SIP1 cells
expressing or nonexpressing exogenous cyclin D1 using a
transwell motility assay. SIP1 strongly activated migration
Figure 3. SIP-1 attenuates cell cycle progression via cyclin D1 down-regulation. (A) RNAi-mediated repression of cyclin D1 leads to
accumulation of A431/SIP1 cells in G1 phase of the cell cycle. FACS analysis of cell cycle distribution of A431/SIP1 cells, in which cyclin D1
expression was reduced either by SIP1 or by RNAi. Control cells were cultured with or without DOX for 48 h. Results are mean SD of three
experiments. Right panel, Western blot analysis of cyclin D1 and Rb expression in A431/SIP1 cells transfected with the negative control
siRNA or cyclin D1-specific siRNA. 20 g of total proteins was loaded in each lane. (B) Exogenous cyclin D1 counteracts the effect of SIP1
on Rb phosphorylation and cell cycle distribution. Clones with simultaneous DOX-regulated expression of SIP1 and cyclin D1 were generated
and the phosphorylation of Rb was analyzed by Western blotting. Bottom, cells were cultured in the presence or absence of DOX for 48 h,
and cell cycle distribution was monitored by FACS. (C) DOX-induced A431/SIP1 and A431/SIP1/cyclinD1-2 cells differently incorporate
BrdU after 40-min pulse labeling. After the labeling, BrdU incorporation was detected by fluorescence microscopy with the monoclonal
anti-BrdU antibody. Total cell number was identified by blue fluorescence (DAPI DNA staining). Proportion of BrdU-positive cells was
quantified in six microscopic fields and presented as mean  SD. The experiment was repeated twice with similar results.
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of cells through the pores of transwell filters in parental
A431/SIP1 cells and in cells expressing exogenous cyclin D1
(clone A431/SIP1/cyclD1-2, Figure 4B). Our data show that
enforced expression of cyclin D1 uncouples cell cycle effects
from key features of SIP1-induced EMT, cell motility, and
invasiveness.
SIP1 Directly Regulates Cyclin D1 Promoter Activity
There are two levels controlling cyclin D1 mRNA abundance
in mammalian cells. Signaling networks, which coordinate
G1/S transition, regulate activity of the cyclin D1 promoter.
In addition, regulation of the cyclin D1 mRNA turnover
plays an important role in the control of cyclin D1 function
(Lin et al., 2000). To explore the possibility that SIP1 activates
degradation of cyclin D1 mRNA, A431/SIP cells were
treated with DOX for 48 h or left untreated and then incu-
bated with ActD for different time periods. In control exper-
iments, the concurrent treatment of cells with ActD and
DOX for 8 h prevented SIP1 transcription and therefore
proved the efficacy of ActD (Figure 5A, right panel). The
application of ActD for 4 or 8 h revealed that cyclin D1
mRNA was very stable in DOX-treated and untreated A431/
SIP1 cells compared with the stability of fosl1 or SIP1 mRNA
(Figure 5A). To quantify the effects of SIP1 on cyclin D1
mRNA stability more accurately, we applied real-time PCR.
The difference in the effects of 4 h ActD treatment on cyclin
D1 mRNA stability in cells maintained with or without DOX
was not statistically significant (p  0.3695; n  5; Figure
5B). To examine whether SIP1 regulates the transcription
rate of cyclin D1, we carried out nuclear run-on assay with
nuclei prepared from DOX-treated or untreated cells. Biotin-
labeled UTP was incorporated into nascent transcripts, and
after the transcriptional reaction was completed, newly syn-
thesized RNA was affinity-purified and subjected to RT-PCR
analysis.
With three primer sets (a scheme in Figure 5C), we dem-
onstrated that SIP1 drastically inhibited the transcription
rate of the cyclin D1 gene. In contrast, transcription of a
SIP1-up–regulated gene, prss11 was much more efficient in
nuclei isolated from DOX-treated cells. In all control reac-
tions, in which nonlabeled UTP was used, no PCR product
was detected (data not shown). From these experiments, we
concluded that repression of cyclin D1 promoter rather than
mRNA destabilization is responsible for cyclin D1 inhibition
in course of SIP1-mediated EMT. To directly address this
issue, we analyzed the in vivo binding of SIP1 to potential
SIP1-binding sites (Z-boxes) located in the vicinity of the
cyclin D1 transcription start site. We carried out ChIP assays
in A431/SIP1 cells maintained with or without DOX for
24 h. After formaldehyde cross-linking, chromatin physi-
cally associated with SIP1 was pulled-down, and cyclin D1
promoter fragments enriched in SIP1-containing chromatin
fraction were identified by quantitative PCR. As negative
control a preimmune serum was used. Data indicated that
three Z-boxes with coordinates 1014 to 1010 (Z-box 1);
857 to 853 (Z-box 2); and 300 to 290 (Z-box 3) are
occupied by SIP1 in DOX-stimulated cells. In contrast, nei-
ther sequences upstream of Z-box 1 (Figure 6A), nor se-
quences containing Z-boxes 4 and 5 located at the first
exon/intron boundary (390 to 409) (data not shown)
were detected in association with SIP1. Next, we aimed to
test whether the physical binding of SIP1 to Z boxes 1–3
resulted in the repression of cyclin D1 promoter activity.
Two luciferase reporters were generated. A wild-type re-
porter (pwtCCND1LUC) contained the 1025 to 18 cyclin
D1 promoter sequence cloned upstream of the firefly lucif-
erase gene. The second reporter (pmutCCND1LUC) had the
same structure but with Z-boxes 1–3 inactivated by a single
nucleotide substitution converting 5-AGGTG to 5-AGATG.
This substitution has been previously shown to block binding
of SIP1 to DNA (Remacle et al., 1999). Transient transfection
experiments demonstrated that the mutation of Z-boxes 1–3
markedly activated reporter activity in SIP1-expressing cells
(Figure 6B). Taken together with the results of ChIP analysis,
these data indicate that SIP1 represses cyclin D1 transcrip-
tional activity via direct interaction with Z-boxes 1–3 in the
cyclin D1 promoter.
An E-Cadherin Dominant Negative Mutant Induces EMT
But Does Not Influence Cell Cycle Progression in A431
Cells
EMT programs encompass deep reorganization of the cy-
toskeleton and modulation of cell adhesion. Significant body
of evidence implicates integrins, cadherins and cytoskeletal
Figure 4. Ectopic expression of cyclin D1 does
not influence SIP1-mediated cell invasion and
motility. (A) Exogenous cyclin D1 does not com-
promise SIP1-activated invasion. DOX-treated
or untreated A431/SIP1 and A431/SIP1/cy-
clinD1-2 cells were allowed to invade into ma-
trigel. Cell number on the underside of the
filter and at the distance of 20 m was quan-
tified after staining with PI. The percentage of
invaded cells was quantified in twelve micro-
scopic fields. The diagram represents mean 
SD of triplicate experiments. (B) Enforced ex-
pression of cyclin D1 does not influence SIP1-
activated cell motility. A431/SIP1 and A431/
SIP1/cyclinD1-2 cells were maintained with or
without DOX for 48 h. Migration was ana-
lyzed in transwell motility assay. Bar graphs
summarize the results of three separate exper-
iments (mean  SD).
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tensions in the control of cell cycle (Walker and Assoian,
2005; Walker et al., 2005). However, given that the effect of
SIP1 on cyclin D1 expression was direct, cell cycle regulation
might be not affected in course of EMT programs, which do
not involve SIP1. To test this, we used a recently generated
model of EMT based on the expression of a dominant neg-
ative E-cadherin mutant (Ec1WVM) in A431 cells (Andersen
et al., 2005). This mutant harbors a Trp2/Ala amino acid
substitution in the first cadherin-like repeat, leading to an
inability of the mutant protein to form trans-dimers. Forty-
eight hours of Ec1WVM expression induced cell scattering
and activated cell invasiveness (Figure 7A). Prolonged ex-
pression of Ec1WVM resulted in activation of vimentin,
down-regulation of cytokeratins, and further increase in cell
motility (Andersen et al., 2005). However, neither long-term
(data not shown), nor short-term Ec1WVM expression (Fig-
ure 7B) inhibited G1/S phase transition in A431 cells. In
agreement with these data, we observed no effects on Rb
phosphorylation or cyclin D1 expression in cells undergoing
EMT in response to Ec1WVM (Figure 7B). These data indi-
cate that in different EMT models, the G1/S transition de-
pends on the nature of EMT-inducing signals.
DISCUSSION
Direct repression of e-cadherin transcription by Snail/Slug
and ZEB-1/SIP1 proteins demonstrated in several epithelial
cell lines is highly relevant to EMT and epithelial tumori-
genesis. However, the functions of Snail/Slug and ZEB-1/
SIP1 are not restricted to the repression of the e-cadherin
gene. A number of genes encoding components of different
epithelial intercellular adhesive complexes are directly or
indirectly repressed by Snail, Slug, ZEB-1, or SIP1 (Ohkubo
and Ozawa, 2004; De Craene et al., 2005b; Vandewalle et al.,
2005; Moreno-Bueno et al., 2006; Aigner et al., 2007; Supple-
mentary Table SIB and this article). Moreover, expression of
exogenous E-cadherin in MDCK/Snail or DLD/Snail cells
was unable to restore epithelial differentiation or to inhibit
Snail-induced invasion (Ohkubo and Ozawa, 2004; De
Craene et al., 2005b). Similarly, we found that ectopic expres-
sion of E-cadherin in A431/SIP1 cells did not revert EMT
initiated by SIP1 induction (data not shown). These data
suggest that Snail/Slug and ZEB-1/SIP1 proteins do not act
through transcriptional repression of e-cadherin, but rather
orchestrate EMT programs via independent and coordi-
nated repression of multiple genes controlling epithelial fea-
tures and by activation of mesenchymal genes.
In addition to the activation of canonical well-described
EMT-related processes (cell dissociation, cell motility and
invasiveness, global changes in gene expression pattern),
SIP1 significantly stimulated adhesion of A431 cells to fi-
bronectin and collagen I (Supplementary Figure S1B). In
contrast, Slug inhibited adhesion of human epidermal ker-
atinocytes to fibronectin and laminin-5 as a result of tran-
scriptional repression of genes coding for 3, 1, and 4
integrin subunits (Turner et al., 2006). In A431 cells, tran-
scription of these genes was not affected by SIP1 (data not
shown), and the mechanism by which SIP1 activated cell–
matrix adhesion remains unclear. However, results reported
by Turner et al. and our data represent a rare example of a
cell feature oppositely regulated by different Snail/Slug and
ZEB-1/SIP1 proteins in two cell lines of common (epider-
mal) origin.
Figure 5. SIP1 regulates cyclin D1 promoter activity rather than the stability of cyclin D1 mRNA. (A) A431/SIP1 cells were maintained with
or without DOX for 48 h. ActD was added for 4 or 8 h and expression of cyclin D1, SIP1, and fosl1 was analyzed by RT-PCR. 28S rRNA was
used as an ActD-insensitive control. Right panel, DOX and ActD were added simultaneously, and transcription of cyclin D1, SIP1, fosl1, and
28S rRNA was analyzed by RT-PCR 8 h later. (B) Quantification of cyclin D1 mRNA levels in A431/SIP1 cells maintained with or without
DOX using real time PCR. Cells were treated with ActD for 4 h, and amplification was performed in triplicate. Data are presented as the
mean  SD. (C) Nuclei were isolated from A431/SIP1 cells maintained with or without DOX for 48 h and subjected to nuclear run-on assay.
Isolation of nuclei, conditions of the reaction, and purification of biotinylated uridine-containing transcripts are described in Materials and
Methods. Isolated transcripts corresponding to GAPDH, prss11, and cyclin D1 genes were amplified by RT-PCR and analyzed in an agarose
gel. The scheme depicts fragments of the cyclin D1 mRNA detected by RT-PCR. Results are representative of two independent experiments.
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Snail/Slug and ZEB-1/SIP1 family members control dis-
tinct EMT programs that are implicated in many aspects of
embryonic development, gastrulation, somitogenesis, and
neural crest migration. It is therefore plausible to speculate
that cancer cells recapitulate some elements of concealed
embryonic differentiation programs to acquire metastatic
capabilities. Given that normal differentiating cells do not
proliferate, the intriguing question arises as to whether the
EMT programs affect cell proliferation in cancer as well.
However, to our knowledge, this issue has not been scru-
pulously addressed. In an important study by Vega et al.
(2004) the expression of Snail has been shown to induce
accumulation of MDCK cells in the G1 phase of the cell
cycle. In addition, Vega et al. demonstrated that Snail inhib-
ited phosphorylation of Rb, lowered expression of cyclins
D2 and D1 and increased expression of p21(Cip1). Cyclin D2
has been shown to be a direct Snail target. However, the role
of particular cell cycle regulators has not been addressed in
this study. Here, we analyzed how an EMT program initi-
ated by the expression of SIP1 affects cell cycle progression.
We found that although SIP1 belongs to a protein family
only distantly related to Snail/Slug, its effect on cell cycle
distribution in human epidermoid A431 cells is similar to
the effects of Snail in MDCK cells and Slug in normal kera-
tinocytes (Turner et al., 2006). Moreover, in the present
study, we demonstrated the essential role of cyclin D1
whose direct transcriptional repression by SIP1 was neces-
sary and sufficient to affect Rb phosphorylation status and to
inhibit progression through G1 into S phase in A431 cells.
Taken together, these observations indicate that targeting
G1/S checkpoint is a common feature of different EMT-
inducing transcription factors in different cell lines, although
the actual mechanisms of this targeting might be different.
Immunohistochemical data on the expression of Snail/
Slug and especially ZEB-1/SIP1 family members in tumor
tissue are limited. A proportion of ZEB1-positive tumors has
been identified by immunohistochemical analysis of aggres-
sive endometrial and non-small lung cancer specimens
(Dohadwala et al., 2006; Spoelstra et al., 2006). In oral squa-
mous cell carcinoma, SIP1 was detected in 27% of tumor
specimens. SIP1 expression correlated with lack of E-cad-
herin immunoreactivity and low disease-specific survival
(Maeda et al., 2005). Similarly, Zhou et al. (2004) described
extended E-cadherin-negative and Snail-positive areas in
breast cancer surgical specimens, and this pattern signifi-
cantly correlated with cancer metastasis. In another study,
only a limited number of single Snail-positive cells has been
detected at the periphery of tumor tissue in cervical squa-
mous carcinoma and colon adenocarcinoma (Franci et al.,
2006). Studies on EMT of MDCK cells (Vega et al., 2004) and
data presented here suggest that cells maintaining control
over G1/S transition and undergoing a rapid EMT in re-
sponse to Snail or SIP1 acquire a growth disadvantage.
Therefore, the functional status of the Rb pathway may
determine the configuration of EMT programs utilized by
cells of growing tumors. In carcinoma cells maintaining
partial control over G1/S restriction point, members of the
Figure 6. SIP1 directly regulates transcription of the cyclin D1
gene. (A) SIP1 interacts with three Z-box sequences in the cyclin D1
promoter in vivo. ChIP analysis of cyclin D1 promoter sequences in
DOX-treated or untreated cells with the 9E10 antibody. As control
an irrelevant antibody was used. Enrichment of SIP1-bound se-
quences was quantified by real-time PCR. Mean  SD are shown.
n  9; *p  0.01; **p  0.001 (t test). (B) Luciferase reporter
constructs pwtCCND1LUC and pmutCCND1LUC were transfected
into A431/SIP1 cells. Cells were cultured in the presence of DOX for
48 h. Assays were carried out in triplicate, and four independent
experiments were performed; a representative result is shown
(mean  SD, n  3). p  0.05 (t test).
Figure 7. E-cadherin dominant negative mu-
tant (Ec1WVM) induces invasion without af-
fecting cell cycle. (A) DOX-activated expres-
sion of myc-tagged Ec1WVM in A431 cells
(clone 31D6) induces cell scattering and inva-
sion. Phase-contrast images of 31D6 cells
treated with DOX for 48 h or left untreated.
Right panel, results of a typical matrigel inva-
sion assay of 31D6 cells. (B) FACS analysis of
31D6 cells cultured in the absence or presence
of DOX for 48 h. Results are means  SD of
three experiments. Right panel, Western blot
analysis of cyclin D1 and Rb expression levels
in DOX-treated (48 h) and untreated A431/
Ec1WVM cells.
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SIP1 and Snail protein families may induce a transient EMT,
which will contribute to metastatic dissemination without
stable repression of epithelial markers (e.g., E-cadherin) in
primary tumors. This hypothesis may explain why complete
EMTs are relatively rarely observed in human cancers
(Christofori, 2006). One of the events perturbing the Rb
pathway is overexpression of cyclin D1 that is frequently
associated with carcinomas in humans (in part, as a result
of amplification of the cyclin D1 gene; Malumbres and
Barbacid, 2001; Knudsen et al., 2006). Concurrent expression
of cyclin D1 and SIP1 in A431 cell line generated cells, which
were capable of proliferating and invading into matrigel at
the same time (Figures 3 and 4). We suggest that accumu-
lated defects in the Rb pathway in vivo would permit a
stable EMT, resulting in the appearance of most aggressive
tumor cell variants.
In contrast to the SIP1 model, functional inhibition of
E-cadherin by a dominant negative E-cadherin mutant in-
duces a gradual EMT in A431 cells without attenuating the
cell cycle (Figure 7). Therefore, prolonged inactivation of
epithelial adhesion by matrix metalloproteinases secreted by
stroma cells or e-cadherin gene mutations may represent a
mechanism of a stable EMT in tumor cells retaining partial
control over G1/S transition.
In conclusion, we have demonstrated that cyclin D1 is a
new direct transcriptional target of SIP1. Taken together
with previously published results (Vega et al., 2004; Turner
et al., 2006), our data suggest that attenuated G1/S phase cell
cycle transition is a common feature of EMT programs in-
duced by Snail/Slug and ZEB-1/SIP1 proteins.
ACKNOWLEDGMENTS
We thank Jiri Lukas (Danish Cancer Society, Copenhagen) for his valuable
comments on the manuscript. We thank Kristin Verschueren (University of
Leuven, Belgium) for pTREmyc-SIP1ZFmut plasmid. We acknowledge the
support from the Department of Cancer Studies and Molecular Medicine
(University of Leicester, United Kingdom) and European Urology Fellowship
Programme. C.V. was supported by the Fund for Scientific Research, Flanders
(FWO) and the “Centrum voor Gewelziekten,” Ghent. G.B. is a postdoctoral
fellow with the FWO. The research by C.V. and G.B. has been supported by
the Association for International Cancer Research (AICR-United Kingdom),
FWO-Flanders and Interuniversitaire Atractiepolen (Belgian Government).
REFERENCES
Aigner, K. et al. (2007). The transcription factor ZEB1 (EF1) promotes tumour
cell dedifferentiation by repressing master regulators of epithelial polarity.
Oncogene (in press). doi: 10.1038/sj.onc.1210508.
Andersen, H., Mejlvang, J., Mahmood, S., Gromova, I., Gromov, P., Lukanidin,
E., Kriajevska, M., Mellon, J. K., and Tulchinsky, E. (2005). Immediate and
delayed effects of E-cadherin inhibition on gene regulation and cell motility in
human epidermoid carcinoma cells. Mol. Cell. Biol. 25, 9138–9150.
Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J., and
De Herreros, A. (2000). The transcription factor snail is a repressor of E-
cadherin gene expression in epithelial tumour cells. Nat. Cell. Biol. 2, 84–89.
Berx, G., Becker, K., Hofler, H., and van Roy, F. (1998). Mutations of the
human E-cadherin (CDH1) gene. Hum. Mutat. 12, 226–237.
Blanco, M. J., Moreno-Bueno, G., Sarrio, D., Locascio, A., Cano, A., Palacios,
J., and Nieto, M. A. (2002). Correlation of Snail expression with histological
grade and lymph node status in breast carcinomas. Oncogene 21, 3241–3246.
Bolos, V., Peinado, H., Perez-Moreno, M., Fraga, M., Esteller, M., and Cano, A.
(2003). The transcription factor Slug represses E-cadherin expression and
induces epithelial to mesenchymal transitions: a comparison with Snail and
E47 repressors. J. Cell Sci. 116, 499–511.
Brockbank, E. C., Bridges, J., Marshall, C. J., and Sahai, E. (2005). Integrin
beta1 is required for the invasive behaviour but not proliferation of squamous
cell carcinoma cells in vivo. Br. J. Cancer. 92, 102–112.
Burstyn-Cohen, T., and Kalcheim, C. (2002). Association between cell cycle
and neural crest delamination through specific regulation of G1/S transition.
Dev. Cell 3, 383–395.
Cano, A., Pe´rez-Moreno, M., Rodrigo, I., Locascio, A., Blanco, M., del Barrio,
M., Portillo, F., and Nieto, M. A. (2000). The transcription factor Snail controls
epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat.
Cell. Biol. 2, 76–83.
Carver, E., Jiang, R., Lan, Y., Oram, K., and Gridley, T. (2001). The mouse snail
gene encodes a key regulator of the epithelial-mesenchymal transition. Mol.
Cell. Biol. 21, 8184–8188.
Christofori, G. (2006). New signals from the invasive front. Nature 441,
444–450.
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L.,
Bruyneel, E., Mareel, M., Huylebroeck, D., and van Roy, F. (2001). The
two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin
and induces invasion. Mol. Cell 7, 1267–1278.
De Craene, B., van Roy, F., and Berx, G. (2005a). Unravelling the signalling
cascades for the Snail family of transcription factors. Cell Signal. 17, 535–547.
De Craene, B., Gilbert, B., Stove, C., Bruyneel, E., van Roy, F., and Berx, G.
(2005b). The transcription factor snail induces tumour cell invasion through
modulation of the epithelial cell differentiation program. Cancer Res. 65,
6237–6244.
Dohadwala, M. et al. (2006). Cyclooxygenase-2-dependent regulation of E-
cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and
snail in non-small cell lung cancer. Cancer Res. 66, 5338–5345.
Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M.,
Berx, G., Cano, A., Beug, H., and Foisner, R. (2005). DeltaEF1 is a transcrip-
tional repressor of E-cadherin and regulates epithelial plasticity in breast
cancer cells. Oncogene 24, 2375–2385.
Elloul, S., Elstrand, M., Nesland, J., Trope, C., Kvalheim, G., Goldberg, I.,
Reich, R., and Davidson, B. (2005). Snail, Slug, and Smad-interacting protein
1 as novel parameters of disease aggressiveness in metastatic ovarian and
breast carcinoma. Cancer 103, 1631–1643.
Franci, C. et al. (2006). Expression of Snail protein in tumor-stroma interface.
Oncogene 25, 5134–5144.
Furusawa, T., Moribe, H., Kondoh, H., and Higashi, Y. (1999). Identification of
CtBP1 and CtBP2 as corepressors of zinc finger-homeodomain factor EF1.
Mol. Cell. Biol. 19, 8581–8590.
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P.,
Taite, H., Scoular, R., Miller, A., and Reeve, A. (1998). E-cadherin germline
mutations in familial gastric cancer. Nature 392, 402–405.
Imamichi, Y., Konig, A., Gress, T., and Menke, A. (2007). Collagen type
I-induced Smad-interacting protein 1 expression downregulates E-cadherin
expression in pancreatic cancer. Oncogene 26, 2381–2385.
Imai, T., Horiuchi, A., Wang, C., Oka, K., Ohira, S., Nikaido, T., and Konishi,
I. (2003). Hypoxia attenuates the expression of E-cadherin via upregulation of
SNAIL in ovarian carcinoma cells. Am. J. Pathol. 163, 1437–1447.
Jiang, R., Lan, Y., Norton, C., Sundberg, J., and Gridley, T. (1998). The Slug
gene is not essential for mesoderm or neural crest development in mice. Dev.
Biol. 198, 277–285.
Jorda, M., Olmeda, D., Vinyals, A., Valero, E., Cubillo, E., Llorens, A., Cano,
A., and Fabra, A. (2005). Upregulation of MMP-9 in MDCK epithelial cell line
in response to expression of the Snail transcription factor. J. Cell Sci. 118,
3371–3385.
Krishnamachary, B., Zagzag, D., Nagashawa, H., Rainey, K., Okuyama, H.,
Baek, J., and Semenza, G. (2006). Hypoxia-inducible factor-1-dependent re-
pression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell
carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 66, 2725–
2731.
Knudsen, K. E., Diehl, J., Haiman, C., and Knudsen, E. S. (2006). Cyclin D1,
polymorphism, aberrant splicing and cancer risk. Oncogene 25, 1620–1628.
Lin, S., Wang, W., Wilson, G., Yang, X., Brewer, G., Holbrook, N., and
Gorospe, N. (2000). Down-regulation of cyclin D1 expression by prostaglan-
din A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol. Cell. Biol.
20, 7903–7913.
Lochter, A., Galosy, S., Muschler, J., Freedman, N., Werb, Z., and Bissel, M.
(1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular
alterations that leads to stable epithelial-to-mesenchymal conversion and
premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139, 1861–
1872.
Maeda, G., Chiba, T., Okazaki, M., Satoh, T., Taya, Y., Aoba, T., Kato, K.,
Kawashiri, S., and Imai, K. (2005). Expression of SIP1 in oral squamous cell
carcinomas: implications for E-cadherin expression and tumour progression.
Int. J. Oncol. 27, 1535–1541.
Malumbres, M., and Barbacid, M. (2001). To cycle or not to cycle: a critical
decision in cancer. Nat. Rev. Cancer 1, 222–231.
SIP1 Directly Represses Cyclin D1
Vol. 18, November 2007 4623
McGarry, L., Winnie, J., and Ozanne, B. W. (2004). Invasion of v-Fos(FBR)-
transformed cells is dependent upon histone deacetylase activity and sup-
pression of histone deacetylase regulated genes. Oncogene 23, 5284–5292.
Mejlvang, J., Kriajevska, M., Berditchevski, F., Bronstein, I., Lukanidin, E. M.,
Pringle, J. H., Mellon, J. K., and Tulchinsky, E. M. (2007). Characterization of
E-cadherin-dependent and -independent events in a new model of c-Fos-
mediated epithelial-mesenchymal transition. Exp. Cell Res. 313, 380–393.
Moreno-Bueno, G. et al. (2006). Genetic profiling of epithelial cells expressing
e-cadherin repressors reveals a distinct role for snail, slug, and e47 factors in
epithelial-mesenchymal transition. Cancer Res. 66, 9543–9556.
Murray, S., and Gridley, T. (2006). Snail family genes are required for left-
right asymmetry determination, but not neural crest formation, in mice. Proc.
Natl. Acad. Sci. USA 103, 10300–10304.
Ohkubo, T., and Ozawa, M. (2004). The transcription factor Snail downregu-
lates the tight junction components independently of E-cadherin downregu-
lation. J. Cell Sci. 117, 1675–1685.
Patrone, G., Puppo, F., Cusano, R., Scaranari, M., Ceccherini, I., Puliti, A., and
Ravazzolo, R. (2000). Nuclear run-on assay using biotin labeling, magnetic
bead capture and analysis by fluorescence-based RT-PCR. BioTechniques 29,
1012–1017.
Peinado, H., Ballestar, E., Esteller, M., and Cano, A. (2004). Snail mediates
E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1
(HDAC1)/HDAC2 complex. Mol. Cell. Biol. 24, 306–319.
Perez-Moreno, M. A., Locascio, A., Rodrigo, I., Dhondt, G., Portillo, F., Nieto,
M. A., and Cano, A. (2001). A new role for E12/E47 in the repression of
E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem.
276, 27424–27431.
Postigo, A., Depp, J., Taylor, J., and Kroll, K. L. (2003). Regulation of Smad
signaling through a differential recruitment of coactivators and corepressors
by ZEB proteins. EMBO J. 22, 2453–2462.
Remacle, J., Kraft, H., Lerchner, W., Wuytens, G., Collart, C., Verschueren, K.,
Smith, J., and Huylebroeck, D. (1999). New mode of DNA binding of multi-
zinc finger transcription factors: deltaEF1 family members bind with two
hands to two target sites. EMBO J. 15, 5073–5084.
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Hofler, H.,
and Becker, K. F. (2002). Differential expression of the epithelial-mesenchymal
transition regulators snail, SIP1 and twist in gastric cancer. Am. J. Pathol. 161,
1881–1891.
Shy, Y., Sawada, J., Sui, G., el-Affar, B., Whetstine, J., Lan, F., Ogawa, H., Luke,
M., Nakatani, Y., and Shi, Y. (2003). Coordinated histone modifications me-
diated by a CtBP co-repressor complex. Nature 422, 735–738.
Spoelstra, N., Manning, N., Higashi, Y., Darling, D., Singh, M., Shroyer, K.,
Broaddus, R., Horwitz, K., and Richer, J. K. (2006). The transcription factor
ZEB1 is aberrantly expressed in aggressive uterine cancers. Cancer Res. 66,
3893–3902.
Sugimachi, K., Tanaka, S., Kameyama, T., Taguchi, K., Aishima, S., Shimada,
M., Sugimachi, K., and Tsuneyoshi, M. (2003). Transcriptional repressor snail
and progression of human hepatocellular carcinoma. Clin. Cancer Res. 9,
2657–2664.
Taki, M., Verschueren, K., Yokoyama, K., Nagayama, M., and Kamata, N.
(2006). Involvement of Ets-1 transcription factor in inducing matrix metallo-
protease-2 expression by epithelial mesenchymal transition in squamous
carcinoma cells. Int. J. Oncol. 28, 487–496.
Thiery, J. P. (2003). Epithelial-mesenchymal transitions in development and
pathologies. Curr. Opin. Cell Biol. 15, 740–746.
Thiery, J. P., and Chopin, D. (1999). Epithelial cell plasticity in development
and tumor progression. Cancer Metastasis Rev. 18, 31–42.
Turner, F., Broad, S., Khanim, F., Jeanes, A., Talma, S., Hughes, S., Tselepis, C.,
and Hotchin, N. (2006). Slug regulates integrin expression and cell prolifera-
tion in human epidermal keratinocytes. J. Biol. Chem. 281, 21321–21331.
van de Putte, T., Maruhashi, M., Francis, A., Nelles, L., Kondoh, H.,
Huylebroeck, D., and Higashi, Y. (2003). Mice lacking Zfhx1b, the gene
that codes for Smad-Interacting Protein-1, reveal a role for multiple neural
crest defects in the etiology of hirschprung disease—mental retardation
syndrome. Am. J. Hum. Genet. 72, 465– 470.
van Grunsven, L. A., Michiels, C., van de Putte, T., Nelles, L., Wuytens, G.,
Verschueren, K., and Huylebroeck, D. (2003). Interaction between Smad-
interacting protein-1 and the corepressor C-terminal binding protein is dis-
pensable for transcriptional repression of E-cadherin. J. Biol. Chem. 278,
26135–26145.
van Grunsven, L. A., Taelman, V., Michiels, C., Opdecamp, K., Huylebroeck,
D., and Bellefroid, E. J. (2006). EF1 and SIP1 are differentially expressed and
have overlapping activities during Xenopus embryogenesis. Dev. Dyn. 235,
1491–1500.
Vandewalle, C., Comijn, J., Craene, B., Vermassen, P., Bruyneel, E., Andersen,
H., Tulchinsky, E., van Roy, F., and Berx, G. (2005). SIP1/ZEB2 induces EMT
by repressing genes of different epithelial cell-cell junctions. Nucleic Acids
Res. 33, 6566–6578.
Vega, S., Morales, A., Ocana, O., Valdes, F., Farbregat, I., and Nieto, M. A.
(2004). Snail blocks the cell cycle and confers resistance to cell death. Genes
Dev. 18, 1131–1143.
Walker, J. L., and Assoian, R. K. (2005). Integrin-dependent signal transduc-
tion regulating cyclin D1 expression and G1 phase cell cycle progression.
Cancer Metastasis Rev. 24, 383–393.
Walker, J. L., Fournier, A. K., and Assoian, R. K. (2005). Regulation of growth
factor signalling and cell cycle progression by cell adhesion and adhesion-
dependent changes in cellular tension. Cytokine Growth Factor Rev. 16,
395–405.
Zhou, B. P., Deng, J., Xia, W., Xu, J., Yan, M., Li, Y. M., Gunduz, M., and Hung,
M. C. (2004). Dual regulation of Snail by GSK-3-mediated phosphorylation
in control of epithelial-mesenchymal transition. Nat. Cell Biol. 6, 931–940.
J. Mejlvang et al.
Molecular Biology of the Cell4624
